Ayobami T Akenroye

Impact of a Bronchiolitis Guideline on ED Resource Use and Cost: A Segmented Time-Series Analysis

A. Stack, M. Samnaliev, Mihail Samnaliev, 2014, Pediatrics.

Implementing an Electronic Medical Record–Based Reminder for Cardiovascular Risk Screening in Rheumatoid Arthritis

W. Mowrey, A. Akenroye, A. Kumthekar, 2016, Arthritis care & research.

Editorial comment on “Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long‐term safety (TATE study)”

P. Eigenmann, Ayobami T Akenroye, Javier S. Cabrera‐Perez, 2024, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Prevalence of anaphylaxis among adults admitted to critical care for severe asthma exacerbation

G. D. de Vos, A. Akenroye, Ayobami T Akenroye, 2018, Emergency Medicine Journal.

Genome-wide Association study of Asthma, Total IgE, and Lung function in a Cohort of Peruvian Children.

E. Bleecker, Á. Cruz, K. Barnes, 2021, The Journal of allergy and clinical immunology.

Lower Use of Biologics for the Treatment of Asthma in Publicly-insured Individuals.

G. Alexander, James Heyward, C. Keet, 2021, The journal of allergy and clinical immunology. In practice.

Underrepresentation of Blacks, Smokers, and Obese patients in Studies of Monoclonal Antibodies for Asthma.

C. Keet, Ayobami T Akenroye, 2020, The journal of allergy and clinical immunology. In practice.

Lung function trajectories in a cohort of patients with moderate‐to‐severe asthma on mepolizumab, omalizumab, or dupilumab

T. Nopsopon, Ayobami T Akenroye, Wanda Phipatanakul, 2024, Allergy.